113 related articles for article (PubMed ID: 7958708)
1. Perspectives on interleukin-2 immunotherapy for colon cancer.
Chang AE
Gastroenterology; 1994 Dec; 107(6):1890-2. PubMed ID: 7958708
[No Abstract] [Full Text] [Related]
2. An interleukin 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosis.
Perrin P; Cassagnau E; Burg C; Patry Y; Vavasseur F; Harb J; Le Pendu J; Douillard JY; Galmiche JP; Bornet F
Gastroenterology; 1994 Dec; 107(6):1697-708. PubMed ID: 7958681
[TBL] [Abstract][Full Text] [Related]
3. [Treatment with butyrate/IL-2 combination in peritoneal carcinomatosis of colonic origin].
Perrin P; Burg C; Vavasseur F; Galmiche JP; Bornet F; Meflah K
C R Acad Sci III; 1993 Jun; 316(6):611-4. PubMed ID: 8019883
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo activated monocytes and adoptive immunotherapy trials in colon cancer patients.
Stevenson HC; Foon KA; Sugarbaker PH
Prog Clin Biol Res; 1986; 211():75-82. PubMed ID: 3515364
[No Abstract] [Full Text] [Related]
5. [Regional intraarterial chemoimmunotherapy in complex treatment of patients with colon cancer complicated by metastatic lesion of the liver].
Goloshchapov-Aksenov RS; Vishnevskiĭ VA; Kokov LS; Istomin NP; Chumak VN; Skrubert VS; Stupakova SV; Teterin AV; Ionkin DA; Elagina LV; Smirnov MN
Khirurgiia (Mosk); 2007; (2):42-8. PubMed ID: 17495831
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of peritoneal dissemination of colon carcinoma in syngeneic mice immunized with interleukin-2-producing cells.
Gunji Y; Tagawa M; Matsubara H; Takenaga K; Sugaya M; Tasaki K; Maeda T; Kondo F; Nakajima K; Suzuki T; Asano T; Ochiai T; Isono K; Sakiyama S
Cancer Lett; 1996 Dec; 109(1-2):171-6. PubMed ID: 9020917
[TBL] [Abstract][Full Text] [Related]
7. Novel immunotherapy for peritoneal dissemination of murine colon cancer with macrophage inflammatory protein-1beta mediated by a tumor-specific vector, HVJ cationic liposomes.
Miyata T; Yamamoto S; Sakamoto K; Morishita R; Kaneda Y
Cancer Gene Ther; 2001 Nov; 8(11):852-60. PubMed ID: 11773975
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of colon cancer metastases in rats with the immunostimulant OM-89.
Lagadec P; Onier N; Bauer J; Tourne S; Jeannin JF
Anticancer Drugs; 1990 Dec; 1(2):143-7. PubMed ID: 2131046
[TBL] [Abstract][Full Text] [Related]
9. Involvement of effector cells in the treatment with endotoxins of peritoneal carcinomatosis induced by colon tumour cells.
Lagadec P; Jeannin JF; Pelletier H; Reisser D; Olsson NO
Anticancer Res; 1989; 9(2):421-5. PubMed ID: 2751266
[TBL] [Abstract][Full Text] [Related]
10. Butyrate. Potential role in colon cancer prevention and treatment.
Velázquez OC; Rombeau JL
Adv Exp Med Biol; 1997; 427():169-81. PubMed ID: 9361842
[No Abstract] [Full Text] [Related]
11. Antitumor effect of synthetic derivatives of lipid A in an experimental model of colon cancer in the rat.
Jeannin JF; Onier N; Lagadec P; von Jeney N; Stütz P; Liehl E
Gastroenterology; 1991 Sep; 101(3):726-33. PubMed ID: 1860636
[TBL] [Abstract][Full Text] [Related]
12. [Vaccination with genetically modified IL-2 secreting cells in a rat model of colonic carcinoma].
Patry Y; Meflah K; Le Pendu J
Bull Cancer; 1996 Mar; 83(3):218-26. PubMed ID: 8695924
[TBL] [Abstract][Full Text] [Related]
13. The effects of peritumoral therapeutic vaccination with IL-2-secreting cells on growth of MC38 colon tumours in mice, local NO production and sentinel lymph node cells activation.
Pajtasz-Piasecka E; Kuśnierczyk H; Krawczyk KP; Piasecki E; Elas M; Radzikowski C
Adv Exp Med Biol; 2001; 495():385-8. PubMed ID: 11774598
[No Abstract] [Full Text] [Related]
14. [Chemotherapy in cancers of the colon].
Seitz JF
Gastroenterol Clin Biol; 1993; 17(2 Pt 3):T2-12. PubMed ID: 7686868
[No Abstract] [Full Text] [Related]
15. Interleukin generation in experimental colon cancer of rats: effects of tumor growth and tumor therapy.
Ravikumar T; Rodrick M; Steele G; Marrazo J; O'Dwyer P; Dodson T; King V
J Natl Cancer Inst; 1985 Apr; 74(4):893-8. PubMed ID: 3872959
[TBL] [Abstract][Full Text] [Related]
16. Immunization against a rat colon carcinoma by sodium butyrate-treated cells but not by interleukin 2-secreting cells.
Patry Y; Douillard JY; Meflah K; Le Pendu J
Gastroenterology; 1995 Nov; 109(5):1555-65. PubMed ID: 7557139
[TBL] [Abstract][Full Text] [Related]
17. Involvement of T lymphocytes in curative effect of a new immunomodulator OM 163 on rat colon cancer metastases.
Onier N; Lejeune P; Martin M; Hammann A; Bauer J; Hirt P; Lagadec P; Jeannin JF
Eur J Cancer; 1993; 29A(14):2003-9. PubMed ID: 8280496
[TBL] [Abstract][Full Text] [Related]
18. Combined surgical and immunotherapeutic treatment of patients with fourth stage colon cancer.
Tarasov VA; Filatov MV; Kisliakova TV; Noskov FS; Koloskov AV; Stavrovietski VV; Onikienko SB; Kletchikov VZ; Lvov IV; Yu Varfolomeeva E; Blizniukov OP; Levina VV; Kiselevski MV
Hybridoma; 1999 Feb; 18(1):99-102. PubMed ID: 10211796
[TBL] [Abstract][Full Text] [Related]
19. Antibody-mediated targeting of differentiation inducers to tumor cells: inhibition of colonic cancer cell growth in vitro and in vivo. A preliminary note.
Otaka M; Singhal A; Hakomori S
Biochem Biophys Res Commun; 1989 Jan; 158(1):202-8. PubMed ID: 2912449
[TBL] [Abstract][Full Text] [Related]
20. [Novel approved form of treatment for colonic cancer with peritoneal metastases - radicality-aimed surgery combined with hyperthermic intraperitoneal chemotherapy].
Lepistö A
Duodecim; 2016; 132(10):912-6. PubMed ID: 27382828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
